Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acitretin and Etanercept Combination for Severe Plaque Psoriasis
NCT00832364Phase 4Withdrawn
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of acitretin in plaque psoriasis, sponsored by GSK. Planned start Oct 2009; status: withdrawn.
02
Drugs
acitretin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00832364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832364.